All mice treated with Ad5-TRP2/PMG3 (10 of 10 mice) succumbed to tumor burden by day 30 PTC, while 8 of 10 mice treated with Ad5-TRP2/PMG4 succumbed to tumor burden by day 45 PTC. The gene discussed is DCT; the disease is neoplasm.